ArticleBioinformation2025
Management of genitourinary syndrome of menopause using diode vaginal laser combined with pelvic floor chair.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genitourinary syndrome of menopause (GSM) is a common condition in postmenopausal women, marked by vaginal atrophy, dyspareunia, urinary incontinence and reduced sexual function. This study evaluated 50 women aged 45-70 years receiving 1470 nm diode laser therapy monthly for three months and pelvic floor chair therapy twice weekly for six weeks. Significant improvements were observed, with VAS scores for vaginal dryness and dyspareunia decreasing markedly, FSFI scores improving and urinary incontinence symptoms reducing as reflected by lower ICIQ-UI SF scores (all p < 0.001). The combined treatment demonstrated substantial symptomatic relief and enhancement of quality of life. Thus, a safe and effective non-hormonal approach for managing GSM is suggested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.